Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 160

Sort by

Sort Order Select

Journal Articles

Analysis of the Genetic Background in Patients with Myeloid Malignancies and Divergent Findings Regarding Blasts As Determined By Cytomorphology and Flow Cytometry

Wolfgang Kern, MD, Manja Meggendorfer, PhD, Constance Baer, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2095.

https://doi.org/10.1182/blood-2019-130157

Published: 2019

Journal Articles

Second-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia with Additional Chromosomal Abnormalities

Naoto Takahashi, MD PhD, Tomoko Yoshioka, MD, Masahiro Kizaki, MD, Tatsuya Kawaguchi, MD, Ritsuro Suzuki, MD PhD, Kazuhito Yamamoto, Kazunori Ohnishi, MD, Tomoki Naoe, MD PhD, Itaru Matsumura, MD PhD

Blood (2019) 134 (Supplement_1): 1640.

https://doi.org/10.1182/blood-2019-123337

Published: 2019

Journal Articles

Application of RNA Sequencing Detects a Large Number of Novel Fusion Transcripts in Patients with AML and MDS

Anna Stengel, PhD, Rabia Shahswar, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 887.

https://doi.org/10.1182/blood-2019-124310

Published: 2019

Journal Articles

Molecular Karyotyping Combined with FISH Offers an Alternative to Chromosome Banding Analysis for Diagnostic Evaluation of Genome Complexity in Acute Myeloid Leukemia

A Borsatti, Elisabeth P. Nacheva, MD PhD

Blood (2019) 134 (Supplement_1): 5188.

https://doi.org/10.1182/blood-2019-131983

Published: 2019

Journal Articles

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

Blood (2019) 134 (Supplement_1): 4287.

https://doi.org/10.1182/blood-2019-126557

Published: 2019

Journal Articles

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Constance Baer, PhD, Wencke Walter, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2735.

https://doi.org/10.1182/blood-2019-128234

Published: 2019

Journal Articles

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Blood (2019) 133 (11): 1205–1216.

https://doi.org/10.1182/blood-2018-09-873083

Published: 2019

Includes: Supplemental data

Journal Articles

Frequency and Clinical Characteristics Associated with Putative CAR Targets ADGRE2, CCR1, CD70, and LILRB2 in Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 5259.

https://doi.org/10.1182/blood-2018-99-113037

Published: 2018

Journal Articles

The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q

Blood (2018) 132 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2018-99-114026

Published: 2018

Journal Articles

DNMT3A and NPM1 Double Mutated AML Is a Phenomenon of the Younger Patient and Could Represent a New Entity

Luca Vincenzo Cappelli, MD, Manja Meggendorfer, PhD, Frank Dicker, PhD, Sabine Jeromin, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Alexander Höllein, MD

Blood (2018) 132 (Supplement 1): 2803.

https://doi.org/10.1182/blood-2018-99-113452

Published: 2018

Journal Articles

PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q

Blood (2017) 130 (Supplement 1): 4275.

https://doi.org/10.1182/blood.V130.Suppl_1.4275.4275

Published: 2017

Journal Articles

Genomic Complexity in Chronic Lymphocytic Leukemia Defined By Array-Based Analysis: Definitions, Associations with Other Biomarkers and Clinical Impact

Blood (2017) 130 (Supplement 1): 4280.

https://doi.org/10.1182/blood.V130.Suppl_1.4280.4280

Published: 2017

Journal Articles

Feasibility of Targeted RNA Sequencing for Routine Diagnostics of B-Cell Precursor ALL

Annette Fasan, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2711.

https://doi.org/10.1182/blood.V130.Suppl_1.2711.2711

Published: 2017

Journal Articles

Mutational Pattern and Clonal Hierarchy in MDS with Monosomy 7

Claudia Haferlach, MD, Wencke Walter, PhD, Anna Stengel, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 2962.

https://doi.org/10.1182/blood.V130.Suppl_1.2962.2962

Published: 2017

Journal Articles

Impact of Infrequently Mutated Genes on Prognosis in 531 Untreated CLL Patients

Sabine Jeromin, PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Torsten Haferlach, MD, Wolfgang Kern, MD

Blood (2017) 130 (Supplement 1): 3005.

https://doi.org/10.1182/blood.V130.Suppl_1.3005.3005

Published: 2017

Journal Articles

RUNX1 Mutations in MDS, s-AML and De Novo AML: Differences in Accompanying Cytogenetic and Molecular Genetic Alterations, Clonal Architecture and Outcome

Anna Stengel, PhD, Wolfgang Kern, MD, Manja Meggendorfer, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 2683.

https://doi.org/10.1182/blood.V130.Suppl_1.2683.2683

Published: 2017

Journal Articles

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Constance Regina Baer, PhD, Verena Muehlbacher, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2017) 130 (Supplement 1): 4219.

https://doi.org/10.1182/blood.V130.Suppl_1.4219.4219

Published: 2017

Journal Articles

Rapid Screening of Targetable Kinase Gene Fusions in Acute Lymphoblastic Leukemia

Esperanza Such, Gayane Avetisyan, Iván Martín, Inés Gómez-Seguí, PhD, Francisca García, Eva Villamón, PhD, Alessandro Liquori, PhD, Francisco Mares, MD, Marta Llop, Paula Amat, MDPhD, Mariam Ibañez, Eva Barragán, Mar Tormo, MD PhD, Guillermo Sanz, MD, Carlos Solano, MD PhD, José Cervera, MD PhD, Blanca Navarro, Miguel A. Sanz, MD

Blood (2017) 130 (Supplement 1): 1436.

https://doi.org/10.1182/blood.V130.Suppl_1.1436.1436

Published: 2017

Journal Articles

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Syed Khizer Hasan, PhD, Nikhil Patkar, MD, Devanand Vishwakarma, MSc, Deepan Rajamanickam, MD, Anant Gokarn, MD, Arvind Sahu, MD, Prashant Tembhare, MD, Sadhana Kannan, MSc, Sumeet Gujral, MD, Bhausaheb Bagal, MD DM, Hasmukh Jain, MD, Hari Menon, MD, Manju Sengar, MD DM, Pratibha Kadam Amare, PhD, Papagudi Ganesan Subramanian, MD, Navin Khattry, MD DM

Blood (2017) 130 (Supplement 1): 3920.

https://doi.org/10.1182/blood.V130.Suppl_1.3920.3920

Published: 2017

Journal Articles

Impact of 9q Deletions on the Classification in AML

Bettina Balk, Anna Stengel, PhD, Manja Meggendorfer, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2017) 130 (Supplement 1): 3925.

https://doi.org/10.1182/blood.V130.Suppl_1.3925.3925

Published: 2017

NARROW

Analysis of the Genetic Background in Patients with Myeloid Malignancies and Divergent Findings Regarding Blasts As Determined By Cytomorphology and Flow Cytometry

Second-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia with Additional Chromosomal Abnormalities

Application of RNA Sequencing Detects a Large Number of Novel Fusion Transcripts in Patients with AML and MDS

Molecular Karyotyping Combined with FISH Offers an Alternative to Chromosome Banding Analysis for Diagnostic Evaluation of Genome Complexity in Acute Myeloid Leukemia

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Frequency and Clinical Characteristics Associated with Putative CAR Targets ADGRE2, CCR1, CD70, and LILRB2 in Acute Myeloid Leukemia

The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q

DNMT3A and NPM1 Double Mutated AML Is a Phenomenon of the Younger Patient and Could Represent a New Entity

PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q

Genomic Complexity in Chronic Lymphocytic Leukemia Defined By Array-Based Analysis: Definitions, Associations with Other Biomarkers and Clinical Impact

Feasibility of Targeted RNA Sequencing for Routine Diagnostics of B-Cell Precursor ALL

Mutational Pattern and Clonal Hierarchy in MDS with Monosomy 7

Impact of Infrequently Mutated Genes on Prognosis in 531 Untreated CLL Patients

RUNX1 Mutations in MDS, s-AML and De Novo AML: Differences in Accompanying Cytogenetic and Molecular Genetic Alterations, Clonal Architecture and Outcome

Comprehensive Genetic Characterization of 63 Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangement of PDGFR-α, PDGFR-β, FGFR1 or PCM1-JAK2

Rapid Screening of Targetable Kinase Gene Fusions in Acute Lymphoblastic Leukemia

Over-Expression of ERG Predicts Poor Outcome in Acute Myeloid Leukemia

Impact of 9q Deletions on the Classification in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only